XML 16 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net loss $ (361,049) $ (812,105)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and other amortization 127,526 130,826
Gain on change in fair value of warrant liability (351,104) (918,801)
Stock-based compensation 368,754 246,412
Write down of inventory, net 135,471 0
Deferred income taxes, net (1,612,534) (28,541)
Changes in assets and liabilities:    
Accounts receivable 78,311,550 (660,996)
Inventory 3,097,407 (144,852)
Prepaid expenses and other assets 241,607 419,395
Accounts payable, accrued expenses and other liabilities (1,881,714) (3,330,241)
Income tax payable (18,398,271) 0
Deferred revenue (2,971,232) 292,591
Net cash provided by/(used in) operating activities 56,706,411 (4,806,312)
Cash flows from investing activities:    
Capital expenditures 0 (13,724)
Cash used in investing activities 0 (13,724)
Cash flows from financing activities:    
Payment of employee tax obligations for common stock tendered (12,533) (13,361)
Repurchase of common stock (6,572,783) (6,529,348)
Cash used in financing activities (6,585,316) (6,542,709)
Net increase/(decrease) in cash, cash equivalents and restricted cash 50,121,095 (11,362,745)
Cash, cash equivalents and restricted cash at the beginning of period 103,138,819 117,890,240
Cash and cash equivalents at end of period $ 153,259,914 $ 106,527,495